Association of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinum-based chemotherapy - Kumari, Ankita; Bahl, Charu; Singh, Navneet; Behera, Digambar; Sharma, Siddharth (Molecular biology reports, 2016)
Keywords: Adult; Aged; Aged, 80 and over; Animal Anatomy; Animal Biochemistry; Antineoplastic Agents - pharmacology; Antineoplastic Agents - therapeutic use; apoptosis; Biomedical and Life Sciences; carcinogenesis; Carcinoma, Squamous Cell - drug therapy; Carcinoma, Squamous Cell - genetics; Carcinoma, Squamous Cell - mortality; Case-Control Studies; Chemotherapy; Codon; confidence interval; DNA damage; DNA repair; Drug Resistance, Neoplasm; drug therapy; Female; females; Genetic Association Studies; Genetic Predisposition to Disease; genotype; Genotype & phenotype; genotyping; Histology; Humans; India; Kaplan-Meier Estimate; Life Sciences; Lung cancer; lung neoplasms; Lung Neoplasms - drug therapy; Lung Neoplasms - genetics; Lung Neoplasms - mortality; Male; males; Medical prognosis; Middle Aged; Morphology; odds ratio; Original Article; patients; Platinum Compounds - pharmacology; Platinum Compounds - therapeutic use; polymerase chain reaction; Polymorphism; Polymorphism, Single Nucleotide; Population genetics; Prognosis; Proportional Hazards Models; regression analysis; restriction fragment length polymorphism; risk; survival rate; Treatment Outcome; Tumor Suppressor Protein p53 - genetics; Young Adult; Genotype; Polymorphisms; 53 codon 72; Survival; Lung cancer; p53 codon 72